These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35481766)

  • 1. Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant.
    Jawad B; Adhikari P; Podgornik R; Ching WY
    J Phys Chem Lett; 2022 May; 13(17):3915-3921. PubMed ID: 35481766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of the tight binding mode to ACE2 triggered by multi-point mutations in the omicron variant: a dynamic insight.
    Zhao X; Xiong D; Luo S; Duan L
    Phys Chem Chem Phys; 2022 Apr; 24(15):8724-8737. PubMed ID: 35373810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant.
    Zhang W; Shi K; Geng Q; Ye G; Aihara H; Li F
    Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2206509119. PubMed ID: 36256797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    Kumar S; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 in relation to global vaccination and booster doses: what is the future of vaccination in the battle against COVID-19?
    Khalid N; Wheeler AM
    Bratisl Lek Listy; 2022; 123(9):631-633. PubMed ID: 36039880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
    Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
    Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omicron Binding Mode: Contact Analysis and Dynamics of the Omicron Receptor-Binding Domain in Complex with ACE2.
    Fazekas Z; Menyhárd DK; Perczel A
    J Chem Inf Model; 2022 Aug; 62(16):3844-3853. PubMed ID: 35849759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of mutations on RBD in the Spike protein of SARS-CoV-2 Alpha, Delta and Omicron variants.
    da Costa CHS; de Freitas CAB; Alves CN; Lameira J
    Sci Rep; 2022 May; 12(1):8540. PubMed ID: 35595778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions.
    Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G; Chakraborty C
    Geroscience; 2022 Apr; 44(2):619-637. PubMed ID: 35258772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations.
    Verkhivker G; Agajanian S; Kassab R; Krishnan K
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation.
    Nguyen HL; Thai NQ; Nguyen PH; Li MS
    J Phys Chem B; 2022 Jun; 126(25):4669-4678. PubMed ID: 35723978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
    Shah M; Woo HG
    Front Immunol; 2021; 12():830527. PubMed ID: 35140714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy.
    Zhao LP; Lybrand TP; Gilbert PB; Payne TH; Pyo CW; Geraghty DE; Jerome KR
    Sci Rep; 2022 Nov; 12(1):19089. PubMed ID: 36352021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
    Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G
    J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein.
    Chakraborty C; Bhattacharya M; Sharma AR; Mallik B
    Int J Biol Macromol; 2022 Oct; 219():980-997. PubMed ID: 35952818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
    Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
    Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern.
    Kim S; Liu Y; Ziarnik M; Seo S; Cao Y; Zhang XF; Im W
    J Comput Chem; 2023 Feb; 44(4):594-601. PubMed ID: 36398990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant.
    Wang WB; Ma YB; Lei ZH; Zhang XF; Li J; Li SS; Dong ZY; Liang Y; Li QM; Su JG
    J Mol Graph Model; 2023 Nov; 124():108540. PubMed ID: 37352723
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.